Novartis Fights Enhanced Damages Bid After $178M Jury Loss | McDermott

McDermott Will & Schulte, a global law firm

COVERAGE

Novartis Fights Enhanced Damages Bid After $178M Jury Loss

November 3, 2021

Read time: 2 min

Thomas P. Steindler

Associé

Washington, DC

Michael S. Nadel

Associé

Washington, DC

Ian B. Brooks

Associé

Washington, DC

Jennifer B. Routh

Associé

Washington, DC

William Gaede

Associé

Silicon Valley, San Francisco

Sarah Chapin Columbia

Associée

Boston

You may also like